New Enterprise Associates 12 Limited Partnership 13D and 13G filings for Viracta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-10 9:40 pm Unchanged |
2020-08-11 | 13D | Viracta Therapeutics, Inc. VIRX |
New Enterprise Associates 12 Limited Partnership | 0 0.000% |
0 (Unchanged) |
Filing |